MedTrace Logo

The Efficacy of Ivermectin in Larger Doses in COVID-19 Treatment

NCT04351347 · Status: RECRUITING · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2021-03-10

No results posted yet for this study

Summary

Efficacy of Ivermectin in larger doses in COVID-19 treatment

Conditions

Interventions

DRUG

Ivermectin

ivermectin

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Principal Investigators

  • sherief Abd-Elsalam, Ass. Prof. · Tanta University - Faculty of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-16
Primary Completion
2030-12-01
Completion
2030-12-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04351347 on ClinicalTrials.gov